During the past decade, The First Affiliated Hospital, Sun Yat-sen University conducted 267 clinical trials. In the 10-year time frame, 267 clinical trials started and 21 clinical trials were completed, i.e. on average, 7.9% percent of trials that started reached the finish line to date. In the past 5 years, 154 clinical trials started and 19 clinical trials were completed. i.e. 12.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The First Affiliated Hospital, Sun Yat-sen University" #1 sponsor was "Sun Yat-sen University" with 75 trials, followed by "First Affiliated Hospital, Sun Yat-Sen University" with 54 trials sponsored, "Janssen Research & Development, LLC" with 12 trials sponsored, "Eli Lilly and Company" with 11 trials sponsored and "Boehringer Ingelheim" with 11 trials sponsored. Other sponsors include 203 different institutions and companies that sponsored additional 140 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The First Affiliated Hospital, Sun Yat-sen University" #1 collaborator was "First Affiliated Hospital, Sun Yat-Sen University" with 27 trials as a collaborator, "West China Hospital" with 9 trials as a collaborator, "Guangdong Provincial People's Hospital" with 7 trials as a collaborator, "Nanfang Hospital of Southern Medical University" with 7 trials as a collaborator and "Sixth Affiliated Hospital, Sun Yat-sen University" with 6 trials as a collaborator. Other collaborators include 316 different institutions and companies that were collaborators in the rest 215 trials.

According to Clinical.Site data, the most researched conditions in "The First Affiliated Hospital, Sun Yat-sen University" are "Hepatocellular Carcinoma" (19 trials), "Gastric Cancer" (9 trials), "IgA Nephropathy" (7 trials), "Breast Cancer" (5 trials) and "Carcinoma, Non-Small-Cell Lung" (5 trials). Many other conditions were trialed in "The First Affiliated Hospital, Sun Yat-sen University" in a lesser frequency.

Most popular intervention types in "The First Affiliated Hospital, Sun Yat-sen University" are "Drug" (236 trials), "Procedure" (50 trials), "Other" (41 trials), "Device" (40 trials) and "Biological" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (47 trials), "Carboplatin" (7 trials), "Lenvatinib" (7 trials), "placebo" (6 trials) and "Amivantamab" (5 trials). Other intervention names were less common.

The vast majority of trials in "The First Affiliated Hospital, Sun Yat-sen University" are 328 trials for "All" genders, 33 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 156 active trials in "The First Affiliated Hospital, Sun Yat-sen University". 12 are not yet recruiting, 104 are recruiting, 37 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 111 completed trials in The First Affiliated Hospital, Sun Yat-sen University, 3 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in The First Affiliated Hospital, Sun Yat-sen University, 24 "Phase 1" clinical trials were conducted, 69 "Phase 2" clinical trials and 113 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 42 trials, and there were also 72 trials that are defined as “Not Applicable".

The First Affiliated Hospital, Sun Yat-sen University has several departments that took part in Clinical trials: "endocrinology department of the first affiliated hospital of Sun Yat-sen University" - 9 trials